Report Detail
Global (United States, European Union and China) Multiple Sclerosis Therapeutics Market Research Report 2019-2025
- RnM3685758 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.
In 2019, the market size of Multiple Sclerosis Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Multiple Sclerosis Therapeutics.
This report studies the global market size of Multiple Sclerosis Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Multiple Sclerosis Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Teva Pharmaceuticals
Sanofi Genzyme
Bayer
Pfizer
Biogen Idec
Merck
AbbVie
Market Segment by Product Type
Beta Interferon
Corticosteroids
Monoclonal Antibodies
Antineoplastic Agents
Others
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
e-Commerce
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Multiple Sclerosis Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Multiple Sclerosis Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Multiple Sclerosis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Beta Interferon
- 1.3.3 Corticosteroids
- 1.3.4 Monoclonal Antibodies
- 1.3.5 Antineoplastic Agents
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Multiple Sclerosis Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 e-Commerce
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Multiple Sclerosis Therapeutics Market Size
- 2.1.1 Global Multiple Sclerosis Therapeutics Revenue 2014-2025
- 2.1.2 Global Multiple Sclerosis Therapeutics Sales 2014-2025
- 2.2 Multiple Sclerosis Therapeutics Growth Rate by Regions
- 2.2.1 Global Multiple Sclerosis Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Multiple Sclerosis Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Multiple Sclerosis Therapeutics Sales by Manufacturers
- 3.1.1 Multiple Sclerosis Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Multiple Sclerosis Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Multiple Sclerosis Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Multiple Sclerosis Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Multiple Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Multiple Sclerosis Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Multiple Sclerosis Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Multiple Sclerosis Therapeutics Market
- 3.6 Key Manufacturers Multiple Sclerosis Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Beta Interferon Sales and Revenue (2014-2019)
- 4.1.2 Corticosteroids Sales and Revenue (2014-2019)
- 4.1.3 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.4 Antineoplastic Agents Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Multiple Sclerosis Therapeutics Sales Market Share by Type
- 4.3 Global Multiple Sclerosis Therapeutics Revenue Market Share by Type
- 4.4 Multiple Sclerosis Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Multiple Sclerosis Therapeutics Sales by Application
6 United States
- 6.1 United States Multiple Sclerosis Therapeutics Breakdown Data by Company
- 6.2 United States Multiple Sclerosis Therapeutics Breakdown Data by Type
- 6.3 United States Multiple Sclerosis Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Multiple Sclerosis Therapeutics Breakdown Data by Company
- 7.2 European Union Multiple Sclerosis Therapeutics Breakdown Data by Type
- 7.3 European Union Multiple Sclerosis Therapeutics Breakdown Data by Application
8 China
- 8.1 China Multiple Sclerosis Therapeutics Breakdown Data by Company
- 8.2 China Multiple Sclerosis Therapeutics Breakdown Data by Type
- 8.3 China Multiple Sclerosis Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Multiple Sclerosis Therapeutics Breakdown Data by Company
- 9.2 Rest of World Multiple Sclerosis Therapeutics Breakdown Data by Type
- 9.3 Rest of World Multiple Sclerosis Therapeutics Breakdown Data by Application
- 9.4 Rest of World Multiple Sclerosis Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Multiple Sclerosis Therapeutics Sales by Countries
- 9.4.2 Rest of World Multiple Sclerosis Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.1.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 Teva Pharmaceuticals
- 10.2.1 Teva Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.2.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.2.5 Teva Pharmaceuticals Recent Development
- 10.3 Sanofi Genzyme
- 10.3.1 Sanofi Genzyme Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.3.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.3.5 Sanofi Genzyme Recent Development
- 10.4 Bayer
- 10.4.1 Bayer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.4.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.4.5 Bayer Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.5.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 Biogen Idec
- 10.6.1 Biogen Idec Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.6.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.6.5 Biogen Idec Recent Development
- 10.7 Merck
- 10.7.1 Merck Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.7.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.7.5 Merck Recent Development
- 10.8 AbbVie
- 10.8.1 AbbVie Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Multiple Sclerosis Therapeutics
- 10.8.4 Multiple Sclerosis Therapeutics Product Introduction
- 10.8.5 AbbVie Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Multiple Sclerosis Therapeutics Sales Channels
- 11.2.2 Multiple Sclerosis Therapeutics Distributors
- 11.3 Multiple Sclerosis Therapeutics Customers
12 Market Forecast
- 12.1 Global Multiple Sclerosis Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Multiple Sclerosis Therapeutics Sales Forecast by Type
- 12.3 Global Multiple Sclerosis Therapeutics Sales Forecast by Application
- 12.4 Multiple Sclerosis Therapeutics Forecast by Regions
- 12.4.1 Global Multiple Sclerosis Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Multiple Sclerosis Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Multiple Sclerosis Therapeutics. Industry analysis & Market Report on Multiple Sclerosis Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Multiple Sclerosis Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Multiple Sclerosis Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
